Jiangsu Aidea Pharmaceutical Group Co., Ltd. (688488.SS) — Stock Score Summary

Jiangsu Aidea Pharmaceutical Group Co., Ltd. (688488.SS) has a MoatMap StockRank of 23/100 based on Quality (43/100), Value (21/100), and Momentum (45/100) factor scores. The current signal is SELL. Jiangsu Aidea Pharmaceutical is a small-scale pharmaceutical player without the global regulatory moats or manufacturing scale required to benefit from the CDMO pricing power cycle.

Jiangsu Aidea Pharmaceutical Group Co., Ltd. develops and commercializes anti-HIV innovative drugs and human protein products. The company developed Ainuovirine, China's first domestically developed, class-1 innovative drug for HIV treatment. It is a niche biopharmaceutical leader in the domestic antiviral market, combining innovative drug R&D with stable human protein manufacturing.

Key Financial Metrics

Price$1.88
Market Cap$965M
P/E (Forward)42.97
Price/Book5.94
Return on Equity-0.3%
Return on Invested Capital3.3%
Debt/Equity66.07
Gross Margin65.9%
Operating Margin11.9%
Revenue Growth-10.0%
Free Cash Flow$-1M

Jiangsu Aidea Pharmaceutical Group Co., Ltd. operates in the Biotechnology industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Jiangsu Aidea Pharmaceutical Group Co., Ltd.’s (688488.SS) StockRank?
MoatMap’s StockRank for Jiangsu Aidea Pharmaceutical Group Co., Ltd. (688488.SS) is 23/100, with a Sell signal. It is a composite of Quality (43), Value (21), and Momentum (45) factor ranks across MoatMap’s 19,000+ stock universe.
Does Jiangsu Aidea Pharmaceutical Group Co., Ltd. have an economic moat?
Jiangsu Aidea Pharmaceutical Group Co., Ltd. (688488.SS) has a Quality factor score of 43/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Jiangsu Aidea Pharmaceutical Group Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for Jiangsu Aidea Pharmaceutical Group Co., Ltd. (688488.SS) is Sell, based on a StockRank of 23/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Jiangsu Aidea Pharmaceutical Group Co., Ltd. in?
Jiangsu Aidea Pharmaceutical Group Co., Ltd. (688488.SS) operates in the Healthcare sector, specifically the Biotechnology industry (China).
Browse all ranked stocks688488.SS deep dive reportAI ChampionsHow we score stocksSense-check another stock